Wealth Trust Axiom LLC Clovis Oncology, Inc. Transaction History

Wealth Trust Axiom LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$1.05 - $2.85 $5,250 - $14,250	5,000 Added 9.09%	60,000 $71,000
Q2 2022 Jul 27, 2022	BUY	$0.63 - $2.96 $14,490 - $68,080	23,000 Added 71.88%	55,000 $99,000
Q1 2022 May 09, 2022	BUY	$1.43 - $3.14 $2,860 - $6,280	2,000 Added 6.67%	32,000 $64,000
Q4 2021 Feb 02, 2022	BUY	$2.7 - $4.76 $8,100 - $14,280	3,000 Added 11.11%	30,000 $81,000
Q3 2021 Oct 14, 2021	SELL	$4.06 - $5.8 $12,179 - $17,400	-3,000 Reduced 10.0%	27,000 $120,000
Q2 2021 Jul 22, 2021	BUY	$5.02 - $7.05 $50,199 - $70,500	10,000 Added 50.0%	30,000 $174,000
Q1 2021 Apr 14, 2021	BUY	$4.81 - $10.34 $38,480 - $82,720	8,000 Added 66.67%	20,000 $140,000
Q4 2020 Feb 04, 2021	BUY	$4.13 - $6.41 $8,260 - $12,820	2,000 Added 20.0%	12,000 $57,000
Q3 2020 Oct 21, 2020	BUY	$4.82 - $7.72 $48,200 - $77,200	10,000 New	10,000 $58,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Trust Axiom LLC with notifications on news.